1Steinbrook, R. Compensation for injured research sub]ects[J].New England Journal of Medicine, 2006,354 : 1871-1873.
2Human Subject Division,University of Washington. The office ofsponsored programs has released an important reminder up-date about industry-sponsored clinical trials [EB/OL]. http://www. Washington, edu/research/hsd/announcements/. q = 264.2008-12-8/2013-3-1.
3Scott,L. D. Research-related injury: problems and solutions[J].Journal of Law,Medicines Ethics,2003,31(3) : 419-428.
4Child,C.,etc. Cost benefits of an institutionally-based subject in-jury treatment and management program [ EB/OL]. https://www. rmis. ucsf. edu, 2013-3-1.
5Workshop and Commissioned Papers. Women and health re-search: ethical and legal issues of including women in clinicalstudies[C]. 1999,volume 2.
6Hockhauser,M. Paying for research related injuries in the US[J].British Medical Journal.2006 ,332 (7541) : 610.
7Guest, S. Compensation for subjects of medical research [J] . themoral rights of patients and the power of research ethics commit-tees. Journal of Medical Ethics,1997, (23) : 181-185.
8Association of the British Pharmaceutical Industry. Guidelines forphase 1 clinical trials (2012 edition)[EB/OL]. http://www. ab-pi. org. uk/our-work/library/guidelines/Pages/default. aspx,2013-3-1.
